The association of resistin with coronary disease in the general population

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 3, 2014, Pages 273-281

  de León, Antonio Cabrera ^a,b,c   González, Delia Almeida ^a,c   Hernández, Ana González ^a,c   Sánchez, José Juan Alemán ^a,c   Díaz, Buenaventura Brito ^a,c   Coello, Santiago Domínguez ^a,c   Rodríguez, Itahisa Marcelino ^a,c   García, José Gregorio Oliva ^a   Jaime, Armando Aguirre ^a   Pérez, María del Cristo Rodríguez ^a,c  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Ischemic heart disease; Population; Resistin; Risk Factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN;

ABDOMINAL OBESITY; ACUTE HEART INFARCTION; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GENDER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN EXPRESSION; SEDENTARY LIFESTYLE; SENSITIVITY ANALYSIS; SMOKING; ADOLESCENT; BLOOD; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESISTIN; YOUNG ADULT;

EID: 84897059015     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.19273     Document Type: Article

References (36)

1. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med, 2006; 355: 2631-2639
2. Qiao XZ, Yang YM, Xu ZR, Yang LA: Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris. J Zhejiang Univ Sci B, 2007; 8: 875-880
3. Wang H, Chen DY, Cao J, He ZY, Zhu BP, Long M: High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome. Chin Med Sci J, 2009; 24: 161-166
4. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, Devaney JM, Fishman C, Stamou S, Canos D, Zbinden S, Clavijo LC, Jang GJ, Andrews JA, Zhu J, Epstein SE: The potential role of resistin in atherogenesis. Atherosclerosis, 2005; 182: 241-248
5. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature, 2001; 409: 307-312
6. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hébert CC: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J, 2000; 19: 4046-4055
7. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun, 2003; 300: 472-476
8. Adeghate E: An update on the biology and physiology of resistin. Cell Mol Life Sci, 2004; 61: 2485-2496
9. Kunnari A, Ukkola O, Paivansalo M, Kesaniemi YA: High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab, 2006; 91: 2755-2760
10. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care, 2004; 27: 2450-2457
11. Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, Samaha FF: Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci, 2005; 9: 161-165
12. Domínguez Coello S, Cabrera de León A, Almeida González D, González Hernández A, Rodríguez Pérez MC, Fernández Ramos N, Brito Díaz B, Castro Fuentes R, Aguirre Jaime A: Inverse association between serum resistin and insulin resistance in humans. Diab Res Clin Pract, 2008; 82: 256-261
13. Chu S, Ding W, Li K, Pang Y, Tang C: Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ J, 2008; 72: 1249-1253
14. Korah TE, Ibrahim HH, Badr EA, ElShafie MK: Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. Postgrad Med J, 2011; 87: 463-467
15. Krecki R, Krzeminska-Pakula M, Peruga JZ, Szcześniak P, Lipiec P, Wierzbowska-Drabik K, Orszulak-Michalak D, Kasprzak JD: Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over 1-year follow-up. Med Sci Monit, 2011; 17: CR26-CR32
16. Weikert C, Westphal S, Berger K, Dierkes J, Möhlig M, Spranger J, Rimm EB, Willich SN, Boeing H, Pischon T: Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab, 2008; 93: 2647-2653
17. Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H, Windler E: Association of plasma resistin levels with coronary heart disease in women. Obes Res, 2005; 13: 1764-1771
18. Lee SH, Ha JW, Kim JS, Choi EY, Park S, Kang SM, Choi D, Jang Y, Chung N: Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. Coron Artery Dis, 2009; 20: 33-39
19. Zhang MH, Na B, Schiller NB, Whooley MA: Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study. J Card Fail, 2011; 17: 24-30
20. Lubos E, Messow CM, Schnabel R, Rupprecht HJ, Espinola-Klein C, Bickel C, Peetz D, Post F, Lackner KJ, Tiret L, Münzel T, Blankenberg S: Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis, 2007; 193: 121-128
21. Ding Q, White SP, Ling C, Zhou W: Resistin and cardiovascular disease. Trends Cardiovasc Med, 2011; 21: 20-27
22. Cabrera de León A, Rodríguez Pérez Mdel C, Almeida González D, Domínguez Coello S, Aguirre Jaime A, Brito Díaz B, González Hernández A, Pérez Méndez LI; grupo CDC: Presentation of the "CDC de Canarias" cohort: objectives, design and preliminary results. Rev Esp Salud Publica, 2008; 82: 519-534
23. Cabrera de León A, Rodríguez-Pérez Mdel C, del Castillo-Rodríguez JC, Brito-Díaz B, Pérez-Méndez LI, Muros de Fuentes M, Almeida-González D, Batista-Medina M, Aguirre-Jaime A: Coronary risk in the population of the Canary Islands, Spain, using the Framingham function. Med Clin (Barc), 2006; 126: 521-526
24. Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV: Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab, 2006; 91: 64-68
25. Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M, Nakamura H, Ohsuzu F: Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol, 2005; 46: 379-380
26. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ: Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 2005; 111: 932-939
27. Filkova M, Haluzik M, Gay S, Senolt L: The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol, 2009; 133: 157-170
28. Boyer JF, Bongard V, Cantagrel A, Jamard B, Gottenberg JE, Mariette X, Davignon JL, Ferrières J, Ruidavets JB, Dallongeville J, Arveiler D, Cambon-Thomsen A, Constantin A: Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort. Arthritis Care Res (Hoboken), 2012; 64: 872-880
29. Jamaluddin MS, Weakley SM, Yao Q, Chen C: Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol, 2012; 165: 622-632
30. Costandi J, Melone M, Zhao A, Rashid S: Human resistin stimulates hepatic overproduction of atherogenic ApoBcontaining lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling. Circ Res, 2011; 108: 727-742
31. Chen C, Jiang J, Lu JM, Chai H, Wang X, Lin PH, Yao Q: Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol, 2010; 299: H193-H201
32. Shin HJ, Park S, Yoon SJ, Choi DS, Cho DK, Kim JS, Ko YG, Choi D, Jang Y, Chung N: Association between serum resistin and carotid intima media thickness in hypertension patients. Int J Cardiol, 2008; 125: 79-84
33. Momiyama Y, Ohmori R, Uto-Kondo H, Tanaka N, Kato R, Taniguchi H, Arakawa K, Nakamura H, Ohsuzu F: Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention. J Atheroscler Thromb, 2011; 18: 108-114
34. Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M, Fukui M, Yoshikawa T, Nakamura N: Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol, 2005; 42: 104-109
35. Luo R, Li X, Jiang R, Gao X, Lu Z, Hua W: Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance. J Int Med Res, 2012; 40: 621-630
36. Al-Daghri NM, Al-Attas OS, Hussain T, Sabico S, Bamakhramah A: Altered levels of adipocytokines in type 2 diabetic cigarette smokers. Diabetes Res Clin Pract, 2009; 83: e37-e39